4//SEC Filing
Celsus Therapeutics Plc. 4
Accession 0001535610-14-000051
$AKTXCIK 0001541157operating
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:15 PM ET
Size
13.6 KB
Accession
0001535610-14-000051
Insider Transaction Report
Form 4
SABBY MANAGEMENT, LLC
10% Owner
Transactions
- Purchase
Common Stock
2014-03-26$6.65/sh+13,300$88,445→ 657,044 total(indirect: See Footnotes) - Purchase
Common Stock
2014-03-25$6.90/sh+303$2,091→ 642,844 total(indirect: See Footnotes) - Purchase
Common Stock
2014-03-26$6.86/sh+900$6,174→ 643,744 total(indirect: See Footnotes) - Purchase
Common Stock
2014-03-27$6.61/sh+1,700$11,237→ 658,744 total(indirect: See Footnotes)
Transactions
- Purchase
Common Stock
2014-03-25$6.90/sh+303$2,091→ 642,844 total(indirect: See Footnotes) - Purchase
Common Stock
2014-03-27$6.61/sh+1,700$11,237→ 658,744 total(indirect: See Footnotes) - Purchase
Common Stock
2014-03-26$6.86/sh+900$6,174→ 643,744 total(indirect: See Footnotes) - Purchase
Common Stock
2014-03-26$6.65/sh+13,300$88,445→ 657,044 total(indirect: See Footnotes)
Mintz Hal
10% Owner
Transactions
- Purchase
Common Stock
2014-03-25$6.90/sh+303$2,091→ 642,844 total(indirect: See Footnotes) - Purchase
Common Stock
2014-03-26$6.86/sh+900$6,174→ 643,744 total(indirect: See Footnotes) - Purchase
Common Stock
2014-03-26$6.65/sh+13,300$88,445→ 657,044 total(indirect: See Footnotes) - Purchase
Common Stock
2014-03-27$6.61/sh+1,700$11,237→ 658,744 total(indirect: See Footnotes)
Footnotes (2)
- [F1]This Form 4 is being filed by Sabby Healthcare Volatility Master Fund, Ltd. ("SHVMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. The Advisor is the investment manager of SHVMF. Mr. Mintz is the manager of the Advisor.
- [F2]The amounts reported herein reflect the entire amount of Issuer's securities held by SHVMF as of each transaction date. Each of the Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either the Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Documents
Issuer
Celsus Therapeutics Plc.
CIK 0001541157
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001541157
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 4:15 PM ET
- Size
- 13.6 KB